We are live on ! Find out more
HTI

Hikari Tsushin Inc Portfolio holdings

AUM $1.45B
1-Year Est. Return 3.37%
This Fund
S&P 500
This Quarter Est. Return
+0.01%
1 Year Est. Return
+3.37%
3 Year Est. Return
+64.01%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.29B
AUM Growth
+$33.2M
Cap. Flow
+$36.7M
Cap. Flow %
2.84%
Top 10 Hldgs %
80.88%
Holding
69
New
4
Increased
11
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
BKLN icon
Invesco Senior Loan ETF
BKLN
+$13.4M
2
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$6.78M
3
FTSL icon
First Trust Senior Loan Fund ETF
FTSL
+$6.77M
4
SOLV icon
Solventum
SOLV
+$3.41M
5
VGIT icon
Vanguard Intermediate-Term Treasury ETF
VGIT
+$3.18M

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$3.61M

Sector Composition

Rank Sector Weight
1 Financials 57.46%
2 Communication Services 10.05%
3 Healthcare 7.7%
4 Industrials 4.68%
5 Technology 3.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRMB icon
51
Trimble
TRMB
$13.6B
$991K 0.08%
17,728
– –
WDS icon
52
Woodside Energy
WDS
$43.2B
$666K 0.05%
35,381
– –
WFC icon
53
Wells Fargo
WFC
$265B
$631K 0.05%
10,631
– –
NTR icon
54
Nutrien
NTR
$31.9B
$550K 0.04%
10,800
– –
LEVI icon
55
Levi Strauss
LEVI
$9.35B
$472K 0.04%
24,500
– –
VWO icon
56
Vanguard FTSE Emerging Markets ETF
VWO
$123B
$463K 0.04%
10,579
– –
VPL icon
57
Vanguard FTSE Pacific ETF
VPL
$8.32B
$366K 0.03%
4,931
– –
CSD icon
58
Invesco S&P Spin-Off ETF
CSD
$227M
$341K 0.03%
4,903
+703
+17% +$49.3K
OXY icon
59
Occidental Petroleum
OXY
$56B
$334K 0.03%
5,297
– –
HII icon
60
Huntington Ingalls Industries
HII
$12.7B
$271K 0.02%
1,100
– –
A icon
61
Agilent Technologies
A
$39.9B
$235K 0.02%
1,815
– –
FONR
62
DELISTED
Fonar
FONR
$227K 0.02%
14,158
– –
ALSN icon
63
Allison Transmission
ALSN
$9.6B
$190K 0.01%
2,500
– –
IBB icon
64
iShares Biotechnology ETF
IBB
$9.53B
$188K 0.01%
1,373
– –
AFL icon
65
Aflac
AFL
$64.5B
$187K 0.01%
2,094
+9
+0.4% +$774
EWBC icon
66
East-West Bancorp
EWBC
$18.1B
$146K 0.01%
2,000
– –
GNTX icon
67
Gentex
GNTX
$4.96B
$68.1K 0.01%
2,020
– –
RPRX icon
68
Royalty Pharma
RPRX
$25.4B
$58.5K ﹤0.01%
2,220
– –
OGN icon
69
Organon & Co
OGN
$3.56B
$12.4K ﹤0.01%
599
– –
1 2
3

Similar funds

CHAM
Clear Harbor Asset Management Stamford, Connecticut $1.45B AUM 23.7% 1-Year Est. Return
SIM
SSI Investment Management Los Angeles, California $1.45B AUM 5.8% 1-Year Est. Return
VIP
Vantage Investment Partners Kansas City, Missouri $1.45B AUM 18.96% 1-Year Est. Return
SIA
Strategic Investment Advisors Farmington Hills, Michigan $1.45B AUM 17.59% 1-Year Est. Return
L7C
Liberty 77 Capital Washington, District of Columbia $1.46B AUM 33.32% 1-Year Est. Return
SWP
Strategic Wealth Partners Independence, Ohio $1.44B AUM 21.2% 1-Year Est. Return
LLL
Lynrock Lake LP Rye Brook, New York $1.46B AUM 17.55% 1-Year Est. Return
ACM
Adelante Capital Management Alameda, California $1.46B AUM 8.98% 1-Year Est. Return

Hikari Tsushin Inc's Q2 2024 Portfolio in Review

As of Q2 2024, Hikari Tsushin Inc held 69 positions worth $1.29B, up 2.6% from $1.26B the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Hikari Tsushin Inc's Q2 2024 filing shows 4 new, 11 increased and 1 reduced positions. Its largest new stake was Solventum: 56,180 shares worth $2.97M. The largest sale was 3M, an estimated $3.61M.

By sector, the portfolio is most concentrated in Financials at 57% of assets, down from 61% a quarter earlier, followed by Communication Services and Healthcare.

  • Hikari Tsushin Inc's largest Q2 2024 buy was Solventum: 56,180 shares worth $2.97M.
  • Hikari Tsushin Inc added most to Invesco Senior Loan ETF in Q2 2024, an estimated $13.4M increase.
  • Hikari Tsushin Inc's biggest Q2 2024 reduction was 3M, cutting an estimated $3.61M.
  • Hikari Tsushin Inc's ten largest holdings make up 81% of its $1.29B portfolio in Q2 2024.
  • Hikari Tsushin Inc opened 4 new positions and closed 0 in Q2 2024.
  • Hikari Tsushin Inc's portfolio value rose 2.6% quarter-over-quarter to $1.29B.

Based on Hikari Tsushin Inc's 13F filing for Q2 2024, filed 8 Aug 2024.